Template:Herpes simplex: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(15 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 16: Line 23:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex overview|Overview]]
Patient Information
|-  
|-  
!
!
Line 22: Line 29:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Patient Information
:[[Genital herpes (patient information)|Genital Herpes]]
|-  
|-  
!
!
Line 28: Line 35:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Genital herpes (patient information)|Genital herpes]]
:[[Congenital herpes (patient information)|Congenital Herpes]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Congenital herpes (patient information)|Congenital herpes]]
[[Herpes simplex overview|Overview]]
|-  
|-  
!
!
Line 52: Line 58:
:[[Herpes simplex neonatorum|Neonatal Herpes]]
:[[Herpes simplex neonatorum|Neonatal Herpes]]


:[[Herpetic whitlow]]
:[[Herpetic whitlow|Herpetic Whitlow]]


:[[Herpes gladiatorum]]
:[[Herpes gladiatorum|Herpes Gladiatorum]]


:[[Mollaret's Meningitis]]
:[[Mollaret's meningitis|Mollaret's Meningitis]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex epidemiology and demographics|Epidemiology and Demographics]]
[[Herpes simplex pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 68: Line 73:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex asymptomatic shedding|Asymptomatic Shedding]]
[[Herpes simplex epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 74: Line 79:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex recurrence|Recurrences and Triggers]]
[[Herpes simplex asymptomatic shedding|Asymptomatic Shedding]]
|-  
|-  
!
!
Line 80: Line 85:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex transmission|Mode of Transmission]]
[[Herpes simplex recurrence|Recurrences and Triggers]]
|-
!
 
|- bgcolor="Pink"
!
[[Herpes simplex transmission#Population At Risk|Risk Factors]]
|-  
|-  
!
!
Line 92: Line 91:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex transmission#Prevention of Transmission|Prevention of Transmission]]
[[Herpes simplex natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
Line 116: Line 114:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Herpes simplex antibody testing|Serology]]
[[Herpes simplex antibody testing|Laboratory Findings]]
|-  
|-  
!
!
Line 122: Line 120:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Herpes simplex direct detection of genital lesions|Direct detection of Genital lesions]]
[[Herpes simplex direct detection of genital lesions|Direct detection of Genital Lesions]]
|-  
|-  
!
!
Line 138: Line 136:
:[[Herpes simplex antiviral therapy|Overview]]
:[[Herpes simplex antiviral therapy|Overview]]


:[[Herpes simplex genitalis antiviral treatment of first episode genital herpes|Antivirals for First Episode]]
:[[Herpes simplex genitalis antiviral treatment of first episode genital herpes|Antivirals for First Episode of Genital Herpes]]
 
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Episode]]
 
:[[Herpes simplex antiviral therapy#Antiviral treatment for Severe Disease|Antivirals for Severe Disease]]   
 
:[[Herpes simplex treatment#Topical treatments|Topical Therapy]]


:[[Herpes simplex treatment#Other drugs|Other Drugs]]  
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Genital Herpes]]  


:[[Herpes simplex alternative therapies |Alternative Therapies]]
|-  
|-  
!
!
Line 154: Line 145:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Herpes simplex primary prevention|Prevention]]
[[Herpes simplex primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
!
[[Herpes simplex complications|Complications]]
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"

Latest revision as of 16:31, 2 March 2017